Bromma, Sweden

Marianne Van Hage

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Alk-Abello A/s, Biomay Ag. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Van Hage. Retrieved from https://idiyas.com/inventor/marianne-van-hage

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0



Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Marianne Van Hage

Introduction

Marianne Van Hage is a prominent inventor based in Bromma, Sweden. She has made significant contributions to the field of allergen research, particularly in the development of recombinant proteins for allergy diagnosis and treatment. With a total of 2 patents, her work has the potential to improve the lives of many individuals suffering from allergies.

Latest Patents

One of her latest patents is focused on a recombinant allergen derived from domestic cats. This invention addresses the common issue of IgE mediated allergy caused by cat dander. The recombinant Fel d 1 she developed exhibits molecular and biological properties similar to its natural counterpart. It features a synthetic gene coding for a direct fusion of Fel d 1 chain 2 to chain 1, resulting in a non-covalently associated homodimer with an apparent molecular weight of 30 kDa. Each subunit displays a disulfide pattern identical to that found in natural Fel d 1, making it suitable for diagnosis and allergen-specific immunotherapy for cat allergies.

Another notable patent is related to a hypoallergenic protein that consists of at least one hypoallergenic molecule derived from an allergen. This protein is fused or conjugated to a second non-allergenic protein or fragment, enhancing its potential for therapeutic applications.

Career Highlights

Throughout her career, Marianne has worked with several notable companies, including Biomay AG and Alk-Abello A/S. Her experience in these organizations has contributed to her expertise in allergen research and development.

Collaborations

Marianne has collaborated with esteemed colleagues in her field, including Rudolf Valenta and Margarete Focke-Tejkl. These partnerships have furthered her research and innovation in allergy-related technologies.

Conclusion

Marianne Van Hage's contributions to allergen research through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also offers practical solutions for allergy sufferers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…